Effects of basic carbohydrate counting versus standard dietary care for glycaemic control in type 2 diabetes (The BCC Study): a randomised, controlled trial

被引:1
|
作者
Ewers, Bettina [1 ]
Blond, Martin B. [1 ]
Bruun, Jens M. [2 ,3 ]
Vilsboll, Tina [1 ,4 ]
机构
[1] Steno Diabet Ctr Copenhagen, Dept Clin & Translat Res, Herlev, Denmark
[2] Steno Diabet Ctr Aarhus, Aarhus, Denmark
[3] Univ Aarhus, Dept Clin Med, Aarhus, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
来源
NUTRITION & DIABETES | 2024年 / 14卷 / 01期
关键词
NUTRITION THERAPY; MANAGEMENT; RECOMMENDATIONS; INDIVIDUALS; VALIDATION; LITERACY; NUMERACY; ADULTS;
D O I
10.1038/s41387-024-00307-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Clinical guidelines recommend basic carbohydrate counting (BCC), or similar methods to improve carbohydrate estimation skills and to strive for higher consistency in carbohydrate intake potentially improving glycaemic control. However, evidence for this approach in type 2 diabetes (T2D) is limited. Objective: To examine the efficacy of a structured education program in BCC as add-on to standard dietary care on glycaemic control in individuals with T2D. Methods: The BCC Study was a randomized, controlled, open-label, parallel-group trial. Individuals with T2D aged 18-75 years with glycated haemoglobin A1c (HbA1c) 53-97 mmol/mol (7.0-11.0%) were randomly assigned (1:1) to BCC or standard dietary care. The primary outcomes were differences in changes in HbA1c or glycaemic variability (calculated as mean amplitude of glycaemic excursions [MAGE]) between groups after six months of intervention. Results: Between September 2018 and July 2021, 48 participants were randomly assigned, 23 to BCC and 25 to standard dietary care. Seven participants did not receive the allocated intervention. From a baseline-adjusted mean of 65 mmol/mol (95% CI 62-68 [8.1%, 7.8-8.4]), HbA1c changed by -5 mmol/mol (-8 to -1 [-0.5%, -0.7 to -0.1]) in BCC and -3 mmol/mol (-7 to 1 [-0.3%, -0.6 to 0.1]) in standard care with an estimated treatment effect of -2 mmol/mol (-7 to 4 [-0.2%, -0.6 to 0.4]); p = 0.554. From a baseline-adjusted mean of 4.2 mmol/l (3.7 to 4.8), MAGE changed by -16% (-33 to 5) in BCC and by -3% (-21 to 20) in standard care with an estimated treatment effect of -14% (-36 to 16); p = 0.319. Only median carbohydrate estimation error in favour of BCC (estimated treatment difference -55% (-70 to -32); p < 0.001) remained significant after multiple testing adjustment. Conclusions: No glycaemic effects were found but incorporating BCC as a supplementary component to standard dietary care led to improved skills in estimating carbohydrate intake among individuals with T2D.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
    Chacra, A. R.
    Tan, G. H.
    Apanovitch, A.
    Ravichandran, S.
    List, J.
    Chen, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (09) : 1395 - 1406
  • [22] Usage of glucometer is associated with improved glycaemic control in type 2 diabetes mellitus patients in Malaysian public primary care clinics: an open-label, randomised controlled trial
    Ismail, Mastura
    Teng, Chong-Lieng
    Omar, Mimi
    Ho, Bee Kiau
    Kusiar, Zainab
    Hasim, Ruziaton
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (07) : 391 - 395
  • [23] Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial
    Zhou, Yongwen
    Deng, Hongrong
    Liu, Hongxia
    Yang, Daizhi
    Xu, Wen
    Yao, Bin
    Yan, Jinhua
    Weng, Jianping
    BMJ OPEN, 2020, 10 (12):
  • [24] The dietary education trial in carbohydrate counting (DIET-CARB Study): study protocol for a randomised, parallel, open-label, intervention study comparing different approaches to dietary self-management in patients with type 1 diabetes
    Ewers, Bettina
    Vilsboll, Tina
    Andersen, Henrik Ullits
    Bruun, Jens Meldgaard
    BMJ OPEN, 2019, 9 (09):
  • [25] The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study
    Thomsen, Mads N.
    Skytte, Mads J.
    Astrup, Arne
    Deacon, Carolyn F.
    Holst, Jens J.
    Madsbad, Sten
    Krarup, Thure
    Haugaard, Steen B.
    Samkani, Amirsalar
    CLINICAL NUTRITION ESPEN, 2020, 39 : 46 - 52
  • [26] Effects of a carbohydrate-reduced high-protein diet delivered with meal kits to Danish people with type 2 diabetes: protocol for a 12-month randomised controlled trial
    Kopp, Luise H. P.
    Sogaard-Hansen, Christina M.
    Zachhau, Karen M.
    Bastkjaer, Rasmus M.
    Andersen, Barbara, V
    Budtz-Jorgensen, Esben
    Byrne, Derek, V
    Chaaban, Nora
    Holst, Jens J.
    Klindt, Trine B.
    Magkos, Faidon
    Ozenne, Brice
    Samkani, Amirsalar
    Skytte, Mads J.
    Madsbad, Sten
    Krarup, Thure
    Thomsen, Mads N.
    BMJ OPEN, 2024, 14 (08):
  • [27] Unsupervised high-intensity interval training improves glycaemic control but not cardiovascular autonomic function in type 2 diabetes patients: A randomised controlled trial
    Cassidy, Sophie
    Vaidya, Vivek
    Houghton, David
    Zalewski, Pawel
    Seferovic, Jelena P.
    Hallsworth, Kate
    MacGowan, Guy A.
    Trenell, Michael I.
    Jakovljevic, Djordje G.
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (01) : 69 - 76
  • [28] Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus
    Nobels, Frank
    Debacker, Noemi
    Brotons, Carlos
    Elisaf, Moses
    Hermans, Michel P.
    Michel, Georges
    Muls, Erik
    CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [29] Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial
    van den Burg, Elske L.
    Schoonakker, Marjolein P.
    van Peet, Petra G.
    van den Akker-van Marle, Elske M.
    Lamb, Hildo J.
    Longo, Valter D.
    Numans, Mattijs E.
    Pijl, Hanno
    DIABETOLOGIA, 2024, 67 (07) : 1245 - 1259
  • [30] Effect of telehealth on glycaemic control: analysis of patients with type 2 diabetes in the Whole Systems Demonstrator cluster randomised trial
    Steventon, Adam
    Bardsley, Martin
    Doll, Helen
    Tuckey, Elizabeth
    Newman, Stanton P.
    BMC HEALTH SERVICES RESEARCH, 2014, 14